• It’s Show Time Klone 4.0 is simmering on the horizon

    At 9am, September 8th EST, Michael Chen, CEO of Great Bay Bio will present on the Medivest Conference, unveiling our Klone 4.0 platform.

    111 2020-09-02
  • "Made in Changping" Young Students Training Camp Visited Great Bay Bio

    [2020/8/5, Dongguan]At 3 o'clock in the afternoon on August 19, a team of young students led by leaders from the Youth League Committee and Human Resources and Social Security Bureau of Changping Town, Dongguan City launched the "Changping Manufacturing" training camp activities and visited Great Bay Bio. Great Bay Bio’s R&D Director Mr. Lan, Human Resources and Administrative Director Ms. Jiang have met with the guests, introduced the company on the spot and held a forum.

    75 2020-08-20
  • Congratulations! Great Bay Bio Was Approved to Establish a Guangdong Doctoral Workstation

    [2020/8/5, Dongguan] Recently, Human Resources and Social Security Department of Guangdong Province has announced to approve Dongguan Taili Biotech Co., Ltd., a subsidiary of Great Bay Bio to establish a Guangdong doctoral workstation.

    100 2020-08-05
  • The First Batch of Phase I Clinical Trial Subjects for GBB’s Class 1 new Drug Has Been Enrolled

    [2020/6/5, Dongguan] On June 4th, the first batch of phase I clinical trial subjects of the recombinant human erythropoietin (Fc) fusion protein injection (rhEPO-Fc project) has been enrolled in Guangdong Provincial People's Hospital.

    178 2020-06-05